Neutrophil-to-lymphocyte ratio, Factor VIII and Antithrombin III: inflammatory-clotting biomarkers in glioma

One of the key difficulties in glioma treatment is our limited ability to consistently assess cancer response or progression either by neuroimaging or specific blood biomarkers. An ideal biomarker could be measured through non-invasive methods such as blood-based biomarkers, aiding both early diagno...

Descripción completa

Detalles Bibliográficos
Autores principales: Koudriavtseva, Tatiana, Villani, Veronica, Lorenzano, Svetlana, Giannarelli, Diana, Di Domenico, Enea Gino, Stefanile, Annunziata, Maschio, Marta, D'Agosto, Giovanna, Pimpinelli, Fulvia, Tanzilli, Antonio, Galiè, Edvina, Pace, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326499/
https://www.ncbi.nlm.nih.gov/pubmed/34345234
http://dx.doi.org/10.17179/excli2021-3831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326499/
https://www.ncbi.nlm.nih.gov/pubmed/34345234
http://dx.doi.org/10.17179/excli2021-3831

Ejemplares similares